PPT-COVID-19 Therapeutics Update

John Veillette PharmD BCPS Col Todd J Vento MD MPH FACP FIDSA IDDUDE 62420 Outline Virologic Therapies Hydroxychloroquine Remdesivir Convalescent plasma Immunologic Therapies Tocilizumab. Soma . Mukherjee. SMU,Chemistry. 5. th. April’2011. Introduction : Protein & important structural features for therapeutics.. Development. Classification. Examples of Protein as targeted delivery device. Microbiome Therapeutics Market report published by Value Market Research is an in-depth analysis of the market covering its size, share, value, growth and current trends for the period of 2018-2025 based on the historical data. This research report delivers recent developments of major manufacturers with their respective market share. In addition, it also delivers detailed analysis of regional and country market. View More @ https://www.valuemarketresearch.com/report/microbiome-therapeutics-market The more the virus circulates, the more the virus will evolve
Most changes have little to no impact on the virus’s properties or behaviour
However, some changes to SARS-CoV-2 lead to the emergence of variants that may affect: David J. Weber, MD, MPH, FIDSA, FSHEA, FRSM (London). Sanders Distinguished Professor of Medicine, Pediatrics and Epidemiology. Associate Chief Medical Officer. Medical Director, Hospital Epidemiology. Atul Kothari MD FIDSA. Elizabeth Woodland . Borella. MPH. Disclosures. None. Arkansas Department of Health. Mission Statement: . To protect and improve the health and well-being of all Arkansans. Vision Statement: . COVID-19: the key facts. Origin: Wuhan China, November 2019. Incubation period: 1-27 days. No vaccine, no treatment. Mortality: 2.3-3.4%. SARS: 10%. Influenza: 0.1%. Virus in US for >6 weeks. Wong et al. Radiology CT Imaging. In press.. Mukherjee. SMU,Chemistry. 5. th. April’2011. Introduction : Protein & important structural features for therapeutics.. Development. Classification. Examples of Protein as targeted delivery device. Director, Geelong Long Covid Clinic. RACGP Webinar . 16/10/2023. Geelong Long Covid Clinic. Established in June 2022. First community Based Long Covid Clinic in Australia . Have seen overall 300+ patients . Oct 4, 2020. Thomas M File Jr. MD, MSc, MACP, FIDSA, FCCP. Chair, Infectious Disease Division. Co-Director, Antimicrobial Stewardship Program; . Summa Health; . Professor of Internal Medicine, Chair ID Section, . Deputy Chief Health Officer. 21 June 2023. Hospitalisation Summary. . Today. This Week average. Last Week average. % Weekly change. % Weekly change unicode. COVID+ patients in hospital. . 315. 3. 27. Constance A. Benson, MD. Professor of Medicine and Global Public Health. University of California San Diego. La Jolla, California. Financial Relationships With Commercial Entities. Dr Benson has served on advisory and data safety monitoring boards for GlaxoSmithKline/ViiV Healthcare, received research grants awarded to her institution from Gilead Sciences, Inc., and serves as a consultant to NDA Partners, LLC. Her spouse has served as a consultant to . April 23, 2020. Agenda. Restarting Elective Surgery. Advocacy . Coding . Q & A. AAOS Video. Send questions to . COVID19@aaos.org. or via the webinar platform question box. AAOS Guidelines on Return to Surgery. Pandemic – November, 2020. Brian L. Strom, MD, MPH. Chancellor Rutgers Biomedical & Health Sciences. Executive Vice President for Health Affairs. Friday. , November . 20, . 2020. Rutgers, The State University of New Jersey. Assist . Government Decision-Making . Regarding Novel . Interventions in South Africa: . Applications from PrEP to COVID-19 Therapeutics. Lise . Jamieson. 1,2. , . Gesine . Meyer-Rath. 1,2,3. , Mariet Benade.